🇮🇳 Alembic Pharmaceuticals Ltd

Press Release 30-10-2026 18:29:27 IST

Overview: Received USFDA final approval for its Abbreviated New Drug Application for Venetoclax Tablets, 10 mg, 50 mg and 100 mg.

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest